Prevention and reversible solubilization of advanced glycation and products (AGE) by organic germanium compounds as derivatives of amino acids
- 87 Downloads
The amino-carbonyl reaction (The Maillard reaction) of bovine lens crystallin, serum albumin or skin collagen with glucose was investigated to find effective means to prevent the formation of Advanced Glycation End Products (AGE) and induce the reversible solubilization of polymerized glycated proteins. The organic germanium compounds (Ge-132, 373, 385), derivatives of amino acids containing germanium as the linker of framework, were combined by the box titration method to determine the dose that would be most effective, compared with Aminoguanidine-HCl (AMG),α-tocopherol (VE), and pirenoxine (Catalin-K, CK). Although AMG suppressed the formation of AGE, effective concentrations were higher than 20 mM. Ge-385, when administered by itself at a low dose, induced the reversible solubilization of AGE made from crystallin, and albumin. The addition of any two reagents such as AMG, VE, CK and Ge-132 or 385 together to proteins lessened the effective range, and the peaks of smaller molecules in the profiles of HPLC and PAGE were quite remarkable. Examination was made of the effects of Ge-132 on the eyes of SAM mice, which show senescence accelerated cataracts at a relatively young age. The prevention of cataract-genesis and induction of reversible transparency of turbid lenses became evident following the administration of Ge-132 to the eyes 4 times a day. The mode of action of organic germanium compounds was demonstrated quite capable of disconnecting the sugar-parts from AGE by decarbonylation, resulting in the formation of glucosone and amino residues, and further leading subsequently to fewer AGE.
KeywordsAmino acids The Maillard reaction Advanced glycation end products (AGE) Reversible solubilization Organic germanium compounds Decarbonylation
Unable to display preview. Download preview PDF.
- 1.Brownlee M, Vlassara H, Koony A, Ulrich P, Cerami A (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629–1632Google Scholar
- 2.Brownlee M, Cerami A, Blassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318(20): 1315–1321Google Scholar
- 3.Hosokawa M, Ashida Y, Tsuboyama T, Chen WH, Takeda T (1988) Cataract in Senescence accelerated mouse (SAM) (II). Development of a new strain of mouse with lateappearing cataract. Exp Eye Res 47: 629–640Google Scholar
- 4.Kawakishi S, Okawa Y, Uchida K (1990) Oxidative damage of protein induced by the amadori compound-copper ion system. J Agricult Food Chem 38: 13–17Google Scholar
- 5.Miyao K, Tanaka N (1988) Carboxyethylgermanium sesquioxide and related organogermanium compounds. Unique synthetic BRM's. Drugs Future 13(5): 441–453Google Scholar
- 6.Monnier VM, Kohn RR, Cerami A (1984) Accelerated age-related browning of human collagen in diabetes mellitus. Proc Nat Acad Sci USA 81(2): 583–587Google Scholar
- 7.Ogino S (1955) Study on the therapy of cataract. 2. Prevention of quinoid-cataract by Catalin and its mode of action. Clin Ophthalmol 11: 272–278 (in Japanese)Google Scholar
- 8.Poehling HM, Neufoff V (1981) Visualization of proteins with a silver “stain”: A critical analysis. Electrophoresis 2: 141–146Google Scholar
- 9.Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, Tomita Y, Yasuhira K, Hamamoto H, Shimizu K, Ishii M, Yamamuro (1981) A new murine model of accelerated senescence. Mech Aging Dev 17: 183–194Google Scholar